Kazia Therapeutics (KZIA) Enterprise Value (2017 - 2025)
Kazia Therapeutics (KZIA) has disclosed Enterprise Value for 6 consecutive years, with -$2.8 million as the latest value for Q2 2025.
- For the quarter ending Q2 2025, Enterprise Value fell 154.82% year-over-year to -$2.8 million, compared with a TTM value of -$2.8 million through Jun 2025, down 154.82%, and an annual FY2025 reading of -$2.8 million, down 159.13% over the prior year.
- Enterprise Value was -$2.8 million for Q2 2025 at Kazia Therapeutics, down from -$1.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.1 million in Q2 2024 and bottomed at -$5.3 million in Q2 2022.
- Average Enterprise Value over 4 years is -$3.2 million, with a median of -$3.1 million recorded in 2023.
- The sharpest move saw Enterprise Value soared 68.83% in 2024, then tumbled 154.82% in 2025.
- Year by year, Enterprise Value stood at -$5.3 million in 2022, then soared by 33.56% to -$3.5 million in 2023, then skyrocketed by 68.83% to -$1.1 million in 2024, then crashed by 154.82% to -$2.8 million in 2025.
- Business Quant data shows Enterprise Value for KZIA at -$2.8 million in Q2 2025, -$1.1 million in Q2 2024, and -$3.5 million in Q2 2023.